Mark Zuccaro

Mark Zuccaro

Warner Norcross + Judd

Contact
View Bio
RSS

Latest Posts › Pfizer

Share:

Second Circuit Rules Anti-Kickback Statute Means No “Corrupt Intent” Required for Liability

On January 9, 2023, the U.S. Supreme Court denied Pfizer Inc.’s petition for a writ of certiorari. The denial brought the pharmaceutical company’s lawsuit challenging the breadth of the federal Anti-Kickback Statute (AKS) to...more

2/20/2023  /  Anti-Kickback Statute , Co-payments , Department of Health and Human Services (HHS) , False Claims Act (FCA) , Food and Drug Administration (FDA) , Medicare , OIG , Pfizer
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide